About us

Out of complexity we create precision

Owkin is an AI biotech that unlocks complex biology to find the right treatment for every patient

What we believe

Transforming drug discovery and development

Owkin was founded by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical onco-hematology, and Gilles Wainrib, PhD, a pioneer in the field of machine learning in biology, in 2016.

We use AI to identify new drug candidates, de-risk and accelerate clinical trials, and build diagnostic solutions that improve patient outcomes.

Why work with Owkin

Owkin is founder-led

Thomas Clozel, MD, Oncologist, and Gilles Wainrib, PhD, Professor of Machine Learning

Global reach

Locations in Boston, New York, London, Paris, Nantes, Geneva and Berlin

Trusted by top 8 biopharmas

Strategic deals with:
Sanofi - AI drug discovery
BMS - AI drug development
MSD - AI diagnostics

357

Top team

Leading experts in data access & data science, medical doctors, biostatisticians, and computational biologists

Scientifically robust

Scientific Advisory Board of the best specialists in their disease area, chaired by Miriam Merad (M.D., Ph.D. Mount Sinai School of Medicine, NYC)

First-in-class AI diagnostic

CE-marked MSIntuit^® CRC screens for MSI in colorectal cancer with only digitized H&E slides

RlapsRisk^® BC helps pathologists and oncologists determine the right treatment pathway for early breast cancer patients

Cutting-edge science & AI

Publications in top scientific journals like Nature Medicine, Nature Communications, and Hepatology

Academic partners

Across Canada, USA, France, Germany, Spain

141

KOLs

Close relationships with PIs including 141 KOLs with a mean H-index of 49

304

Well-funded

Million dollars raised from leading biopharma companies (Sanofi & BMS) and venture funds (F-Prime, Google Ventures & Bpifrance Large Ventures, among others)

Leadership team

We work together to outsmart disease

Meet our leadership team, board, and investors

Learn more about what we do

AI-powered drug discovery

We develop state-of-the-art, AI-based computational technologies using rich multimodal patient data to discover new treatments.

Drug discovery AI engines

AI-powered drug development

We combine cutting-edge machine learning and biology to de-risk and accelerate clinical trials to advance drug development.

Learn more about Waiv

A fuller patient picture

We deliver AI diagnostics that integrate seamlessly into the digital pathology workflow to support accurate and timely diagnosis.

Digital pathology AI